Regarding lack of access to the Bridge Program, we want to clarify the following: Under federal law, Medicare Part D plans cannot cover medications prescribed for weight loss Medications that are FDA-approved for both weight loss and other indications may only be covered by Part D plans for non-weight loss indications. This Bridge Program is a trial of a way to address the particular problem of Part D restrictions on weight-loss prescriptions
They are rapidly inactivated by dipeptidyl peptidase-4 (DPP-4)
According to a clinical trial of Ozempic, after 68 weeks on the medication, 86.4% of participants lost 5% or more of their body weight, and 69.1% lost 10% or more of their body weight. While weight loss can bring about health benefits, losing weight rapidly can also cause a decrease in muscle mass, lessen bone density, and lower your resting metabolic rate, leading to sarcopenia the gradual loss of muscle mass, strength, and function
Mistake #1: Not Eating Enough Protein The problem: When appetite tanks, protein is often the first thing to go
Related Reading: FAQs About GLP-1 Medications What About GLP-2
Blood Sugar Regulation Helps stabilize blood sugar levels, reducing spikes and crashes
